Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 32

Cited In for PubMed (Select 18316751)

1.

Utility of EBUS-TBNA for diagnosis of mediastinal tuberculous lymphadenitis: a multicentre Australian experience.

Geake J, Hammerschlag G, Nguyen P, Wallbridge P, Jenkin GA, Korman TM, Jennings B, Johnson DF, Irving LB, Farmer M, Steinfort DP.

J Thorac Dis. 2015 Mar;7(3):439-48. doi: 10.3978/j.issn.2072-1439.2015.01.33.

2.

Diagnostic Values of the QuantiFERON-TB Gold In-Tube Assay Carried out in China for Diagnosing Pulmonary Tuberculosis.

Xia H, Wang X, Li F, Longuet C, Vernet G, Goletti D, Zhao Y, Lagrange PH.

PLoS One. 2015 Apr 13;10(4):e0121021. doi: 10.1371/journal.pone.0121021. eCollection 2015.

3.

T-cell immunophenotyping distinguishes active from latent tuberculosis.

Pollock KM, Whitworth HS, Montamat-Sicotte DJ, Grass L, Cooke GS, Kapembwa MS, Kon OM, Sampson RD, Taylor GP, Lalvani A.

J Infect Dis. 2013 Sep;208(6):952-68. doi: 10.1093/infdis/jit265.

4.

Feasibility of the Interferon-γ Release Assay for the Diagnosis of Genitourinary Tuberculosis in an Endemic Area.

Kim JK, Bang WJ, Oh CY, Yoo C, Cho JS.

Korean J Urol. 2013 Feb;54(2):123-6. doi: 10.4111/kju.2013.54.2.123. Epub 2013 Feb 18.

5.

Establishing the diagnosis of tuberculous vertebral osteomyelitis.

Colmenero JD, Ruiz-Mesa JD, Sanjuan-Jimenez R, Sobrino B, Morata P.

Eur Spine J. 2013 Jun;22 Suppl 4:579-86. doi: 10.1007/s00586-012-2348-2. Epub 2012 May 11. Review.

6.

In routine UK hospital practice T-SPOT.TB™ is useful in some patients with a modest pre-test probability of active tuberculosis.

Turtle L, Kemp T, Davies GR, Squire SB, Beeching NJ, Beadsworth MB.

Eur J Intern Med. 2012 Jun;23(4):363-7. doi: 10.1016/j.ejim.2012.01.002. Epub 2012 Feb 7.

7.

Comparison of screening strategies to improve the diagnosis of latent tuberculosis infection in the HIV-positive population: a cohort study.

Pollock KM, Tam H, Grass L, Bowes S, Cooke GS, Pareek M, Montamat-Sicotte D, Kapembwa M, Taylor GP, Lalvani A.

BMJ Open. 2012 Mar 1;2(2):e000762. doi: 10.1136/bmjopen-2011-000762. Print 2012.

8.

Screening of healthcare workers for tuberculosis: development and validation of a new health economic model to inform practice.

Eralp MN, Scholtes S, Martell G, Winter R, Exley AR.

BMJ Open. 2012 Mar 1;2(2):e000630. doi: 10.1136/bmjopen-2011-000630. Print 2012.

9.

Novel M tuberculosis antigen-specific T-cells are early markers of infection and disease progression.

Dosanjh DP, Bakir M, Millington KA, Soysal A, Aslan Y, Efee S, Deeks JJ, Lalvani A.

PLoS One. 2011;6(12):e28754. doi: 10.1371/journal.pone.0028754. Epub 2011 Dec 28.

10.

Diagnosing latent tuberculosis in high-risk individuals: rising to the challenge in high-burden areas.

Kasprowicz VO, Churchyard G, Lawn SD, Squire SB, Lalvani A.

J Infect Dis. 2011 Nov 15;204 Suppl 4:S1168-78. doi: 10.1093/infdis/jir449. Review.

11.

Adjunctive tests for diagnosis of tuberculosis: serology, ELISPOT for site-specific lymphocytes, urinary lipoarabinomannan, string test, and fine needle aspiration.

Achkar JM, Lawn SD, Moosa MY, Wright CA, Kasprowicz VO.

J Infect Dis. 2011 Nov 15;204 Suppl 4:S1130-41. doi: 10.1093/infdis/jir450. Review.

12.

Interferon release does not add discriminatory value to smear-negative HIV-tuberculosis algorithms.

Rangaka MX, Gideon HP, Wilkinson KA, Pai M, Mwansa-Kambafwile J, Maartens G, Glynn JR, Boulle A, Fielding K, Goliath R, Titus R, Mathee S, Wilkinson RJ.

Eur Respir J. 2012 Jan;39(1):163-71. doi: 10.1183/09031936.00058911. Epub 2011 Jun 30.

13.

A mycolic acid-specific CD1-restricted T cell population contributes to acute and memory immune responses in human tuberculosis infection.

Montamat-Sicotte DJ, Millington KA, Willcox CR, Hingley-Wilson S, Hackforth S, Innes J, Kon OM, Lammas DA, Minnikin DE, Besra GS, Willcox BE, Lalvani A.

J Clin Invest. 2011 Jun;121(6):2493-503. doi: 10.1172/JCI46216. Epub 2011 May 16.

14.

Limited added value of T-SPOT.TB blood test in diagnosing active TB: a prospective bayesian analysis.

Boyd AE, Ashcroft A, Lipman M, Bothamley GH.

J Infect. 2011 Jun;62(6):456-61. doi: 10.1016/j.jinf.2011.04.003. Epub 2011 Apr 15.

15.

Screening of immigrants in the UK for imported latent tuberculosis: a multicentre cohort study and cost-effectiveness analysis.

Pareek M, Watson JP, Ormerod LP, Kon OM, Woltmann G, White PJ, Abubakar I, Lalvani A.

Lancet Infect Dis. 2011 Jun;11(6):435-44. doi: 10.1016/S1473-3099(11)70069-X. Epub 2011 Apr 20.

16.

Recent developments in treatment of latent tuberculosis infection.

Menzies D, Al Jahdali H, Al Otaibi B.

Indian J Med Res. 2011 Mar;133:257-66. Review.

17.

Rv3615c is a highly immunodominant RD1 (Region of Difference 1)-dependent secreted antigen specific for Mycobacterium tuberculosis infection.

Millington KA, Fortune SM, Low J, Garces A, Hingley-Wilson SM, Wickremasinghe M, Kon OM, Lalvani A.

Proc Natl Acad Sci U S A. 2011 Apr 5;108(14):5730-5. doi: 10.1073/pnas.1015153108. Epub 2011 Mar 22.

18.

Whole-blood flow-cytometric analysis of antigen-specific CD4 T-cell cytokine profiles distinguishes active tuberculosis from non-active states.

Sester U, Fousse M, Dirks J, Mack U, Prasse A, Singh M, Lalvani A, Sester M.

PLoS One. 2011 Mar 15;6(3):e17813. doi: 10.1371/journal.pone.0017813.

19.

Enumeration of functional T-cell subsets by fluorescence-immunospot defines signatures of pathogen burden in tuberculosis.

Casey R, Blumenkrantz D, Millington K, Montamat-Sicotte D, Kon OM, Wickremasinghe M, Bremang S, Magtoto M, Sridhar S, Connell D, Lalvani A.

PLoS One. 2010 Dec 14;5(12):e15619. doi: 10.1371/journal.pone.0015619.

20.

Enzyme-linked immunospot assay (ELISPOT): Quantification of Th-1 cellular immune responses against microbial antigens.

Chambers IR, Cone TR, Oswald-Richter K, Drake WP.

J Vis Exp. 2010 Nov 23;(45). pii: 2221. doi: 10.3791/2221.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk